Microbiomes – Products

Zymo Research Corp., proudly announces the launch of the Quick-DNA/RNA™ Water Kit. This product provides reliable total DNA/RNA recovery from water samples.

At the 72nd ASMS meeting, Bruker Corporation (Nasdaq: BRKR) launches the new top-of-the-line timsTOF Ultra 2 system with significantly further enhanced sensitivity for deep profiling of small cells and subcellular organelles.

Glox Therapeutics, announced it has raised £4.3M in seed funding to develop effective targeted therapeutics against antibiotic-resistant Gram-negative bacteria.

Building on the MAS-seq concatenation method, these three new kits can significantly increase throughput in RNA application.

Owlstone Medical has announced the launch of OMED Health, a dedicated, patient-centric brand and digital platform that will offer patients and clinicians access to breath-based diagnostic tests, point-of-care devices and support resources for a range of conditions.

Current in vitro models of the small intestine offer limited predictivity due to their reliance on immortalized cell lines and static culture. To better predict human response to drug candidates, researchers need a model than can more closely recreate the intestinal microenvironment.

CN Bio has announced it has secured the licensing rights to a novel tool for modelling the gut microbiome, GuMI, from Massachusetts Institute of Technology (MIT) and Northeastern University.

Celemics co-founder and CEO Dr. Hyoki Kim announced a partnership with Strand Life Sciences to develop a bioinformatics solution capable of providing users with an accelerated means of producing high-quality,

Microbioreactor technology is accelerating and increasing automation capabilities with the launch of the new BioLector XT Microbioreactor.

Download this case study to learn more about how Thermo Scientific Core LIMS™ and Core ELN™ software solutions are supporting efforts to develop the human microbiome into a new modality for drug development.